Sentiment Analysis of the earnings transcript to help figure out if there are any bullish or bearish sentiments that could be gathered from it. We're doing ML and AI based analysis on the earnings call to get some more insights.
Please consider a small donation if you think this website provides you with relevant information
| Statement |
|---|
| We expect good results |
| We are confident that we and our investors will be rewarded by them |
| They are nearly 60 % of that group expect increased revenues over '24, and nearly 70% expect improved profitability during that same period |
| In short, we expect to rebound in Q4 and are optimistic about the upcoming year |
| That's a real positive for us going into 2024, especially with the two products you described |
| So that's a positive for us |
| Our technology is expanding in the SIMPAS area, Brazil, I'm excited about Brazil simply because that's a great market access tool for us |
| To that end, in the second quarter, we reached out to one of our Board members, Mark Bassett, who has a strong history of improving profits in a number of businesses, to take a look at our operations and consultation with our senior management team |
| We saw a good strong quarter in LatAm and Mexico in October |
| First, the farm economy is strong, with relatively stable commodity pricing |
| I will say in October, in our in our OHP and our AMGARD lines, we saw very strong quarters |
| But just taking the fact that we had no Aztec in the fourth quarter at all and that's really generally turning our biggest quarter for Aztec, having Dacthal for the last four quarters, those who loan lead us to be very strong on what we're going to see in Q4 |
| So if you really read some of the text of the market in general, I think we're going to see good acquisition opportunities, both on the business front, but also on the talent front because some people will be downsizing so we can strengthen our team where necessary |
| The addition of NewLeaf products will bolster Green Solutions growth in future years |
| NewLeaf brings to us its proprietary microbial library, proven research and development capabilities and best-in-class product offering of naturally occurring microbes |
| We are 70% complete on our production of Aztec, our leading corn soil insecticide, and sales are strong for the quarter |
| So we've got a pretty good optimism of outlook for Q4 |
| As in the past, our lending group, which includes banks and farm credits that are very familiar with the global agricultural industry, was supportive and acted quickly to amend the senior credit facility to give us a secure runway through to September of 2024 |
| And it was interesting, the season trade business is up and healthy and positive pricing and is subjected to this downbeat sort of backdrop |
| As we mentioned in our earnings release and as reflected in Slide 18, we expect to see a rebound in the fourth quarter |
| Within our industry, there has been a great sense of optimism about '24 |
| So I would say, looking at - as you look, I mean, Greens, I think margins were holding strong |
| These measures include a variety of parameters such as working capital management, greater factory efficiency, operating expense control reduced flaws and freight and lower debt and interest expense |
| And one of the things we're happy about this year launching into - well I guess I think we're getting off this year with our BioWake -- David Johnson Yes |
| We believe that we will be able to reduce inventory to more normal levels as sales demand normalizes |
| Also note that we expect that sales of our Green Solutions business will increase by about 10% in in 2023 as compared to 2022 |
| Due to our rapid growth, our next evolution are phase is to strengthen the support of our enterprise with fully-integrated systems and optimal organizational design |
| We have focused on driving improvements in gross margin and achieving greater operational efficiency |
| So as such, there's been a strong look at each of our inventory items globally and targets that are set to bring those down dramatically from where they have been particularly of concerned or products that we may be storing that are lower-margin products |
| So, therefore, we see much more opportunities |
| Statement |
|---|
| With regard to our sales performance for the third quarter of 2023, the company's net sales decreased by 2% to $150 million as compared to $152 million last year |
| Furthermore, during the last four quarters, the company has suffered from some logistics challenges resulting in the unavailability of two of our premium products, Aztec and Dacthal |
| sales declined by 1%, compared to prior year to $87 million, and our international sales decreased by 3% to $63 million |
| crop business and pressure from low-cost Chinese produced generic products in Brazil and Central America |
| This resulted in a 13% decrease in gross profit, $43.84 million in 2023 and $49.638 million in 2022 and a consequent gross margin declined to 29% of net sales in 2023 from 33% in the same period of last year |
| That said, I note that some of our peers have indicated continued channel inventory headwinds in certain geographical locations |
| Our domestic sales suffered a decline in sales of 14%, while our international sales were down 3% as compared to the comparable period last year |
| On Slide 15, you can see that for the nine months of 2023, our sales are down 10% and gross profit decreased by 17% |
| The decrease in sales can mainly be attributed to destocking by customers, managing their working capital levels due to high interest rates, the unavailability of one of our premium herbicides and in our businesses in Central and South America, the influence of low-cost generic products exported to multiple markets from China-based suppliers working within a strained economy |
| This is a challenging time for American Vanguard and for our entire sector |
| With respect to net sales for year-to-date, those peers averaged a decline of about 13%, while we were down about 10% |
| To put our performance in perspective and depict it on Slide 19, we reviewed recent financial statements of a set of our publicly traded peers and found that with respect to Q3 '23, those peers averaged a decline in net sales of 21%, while we were down 2% |
| And then also, we have copper products that come from Norway, and there was strong generic pets in copper that affected their margins down there |
| We have seen more challenge to our margin in the last couple of cycles as lower cost goods - or goods that are oversupplied moved through the channel |
| We did have a pretty good third quarter last year, which definitely affected this year's profitability as we look at the margins |
| The decline in gross profit for the three months ended September 30th is due to slightly lower sales as we manage through the global destocking process, unavailability of Dacthal for the U.S |
| The reduction in gross profit for the nine months ended September 30 is consistent with the three months and resulted from lower overall sales reflecting global destocking unavailability of our premium herbicide Dacthal and the effect of Chinese produced low-priced generic products in our markets in Central and South America |
| And as such, again, we know our corn soil insecticides are extremely low, particularly our Aztec was down to about 7.5% and normal is probably in that 27%, 28% range |
| Third, as a result of the 23 destocking activity by our customers on the whole, channel inventory of many of our products remains low |
| Well, I hope this is the last quarter for some time to come where we do not meet expectations |
Please consider a small donation if you think this website provides you with relevant information